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Materials and Methods  
Unless otherwise stated, all reactions were carried out under air atmosphere. 
Reaction progress was monitored by thin-layer chromatography (TLC) or Agilent 1290 U
HPLC-MS.  TLC was performed using E. Merck silica gel 60 F254 precoated glass plates 
(0.25 mm) and visualized by UV fluorescence quenching, p-anisaldehyde, or KMnO4 
staining.  Silicycle SiliaFlash® P60 Academic Silica gel (particle size 40–63 nm) or 230-
400 Mesh 60 Ǻ Silica Gel (Merck Inc.). was used for flash chromatography. All 
alkynylation reactions were performed in 10 ml vial sealed with a screw cap. At the 
Gwangju Institute of Science and Technology (GIST) all NMR spectra was recorded on a 
JEOL spectrometer, operating at 400 MHz or 300 MHz for 1H NMR and at 100 MHz or 
75 MHz for 13C NMR. At the California Institute of Technology (Caltech), 1H NMR 
spectra were recorded on Bruker 400 MHz or Varian Mercury 300 MHz spectrometers.  
13C NMR spectra were recorded on Bruker 400 MHz spectrometer (101 MHz). 19F NMR 
spectra were recorded on Varian Mercury 300 MHz spectrometer (282 MHz). Data for 1H 
NMR are reported as follows: chemical shift (δ ppm) (multiplicity, coupling constant 
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(Hz), integration).  Multiplicities are reported as follows: s = singlet, d = doublet, t = 
triplet, q = quartet, p = pentet, sept = septuplet, m = multiplet, br s = broad singlet, br d = 
broad doublet, app = apparent.  Data for 13C NMR are reported in terms of chemical 
shifts (δ ppm).   All chemical shifts for 1H and 13C NMR were referenced to residual 
signals from CDCl3 (1H) 7.26 ppm and (13C) 77.16 ppm. High-resolution mass spectra 
(HRMS) were recorded on a JEOL JMS-700 MStation mass spectrometer.  At the GIST, 
Infrared (IR) spectra were obtained on a Nicolet iS10 FT-IR spectrometer with an ATR 
unit and recorded in wave numbers (cm-1). At Caltech, the IR spectra were obtained using 
Perkin Elmer Spectrum BXII spectrometer or Nicolet 6700 FTIR spectrometer using thin 
films deposited on NaCl plates and reported in frequency of absorption (cm–1) High-
performance liquid chromatography (HPLC) was performed on an Agilent 1260 Infinity 
Series machine equipped with a variable wavelength detector and Daicel Chiralpak I 
Series columns (0.46 cm X 25 cm). Analytical SFC was performed with a Mettler SFC 
supercritical CO2 analytical chromatography system utilizing Chiralpak (AD-H, AS-H or 
IC) or Chiralcel (OD-H, OJ-H, or OB-H) columns (4.6 mm x 25 cm) obtained from 
Daicel Chemical Industries, Ltd. High resolution mass spectra (HRMS) were obtained 
from Agilent 6200 Series TOF with an Agilent G1978A Multimode source in electrospray 
ionization (ESI+), atmospheric pressure chemical ionization (APCI+), or mixed 
ionization mode (MM: ESI-APCI+), or obtained from Caltech mass spectrometry 
laboratory. Specific optical rotations were measured with a Jasco P-2000 polarimeter 
operating on the sodium D-line (589 nm), using a 100 mm path-length cell and are 
reported as: [α]DT (concentration in 10 mg/1 mL, solvent). Yields refer to isolated yield of 
analytically pure material, unless otherwise noted.  
All chemicals were purchased from Aldrich, Acros, TCI, or Alfa-Aesar Chemical 
Co. and used as received unless otherwise noted.  At GIST, anhydrous tetrahydrofuran 
(THF), diethyl ether (Et2O) and dichloromethane (CH2Cl2) were dried using J.C. Meyer 
solvent purification system. Hexane was distilled from calcium hydride (CaH2). At 
Caltech, solvents were dried by passage through an activated alumina column under 
argon. Unless specified, all the other chemicals were purchased from Sigma-Aldrich Co., 
Acros Organics, TCI, Alfa Aesar, and Strem Chemicals Inc. and were used as received 
without further purification. 
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Synthesis of Salen-Crown Ether Ligands 
 
L2 and L4 are both known compounds, and were synthesized according to previously 
reported procedures.1,2  
 
General Procedure for Aldehyde Synthesis  
              
Spectroscopic Data for Ligand Intermediates 
 
 
 
 
6-bromo-2,3-dihydroxybenzaldehyde (SI1):   To a flame-dried round bottom flask 
under argon was added 6-bromo-2-hydroxy-3-methoxybenzaldehyde (5.74 g, 24.8 mmol, 
1.0 equiv) and methylene chloride (50 mL). The solution was cooled to –78 °C and boron 
tribromide (7.1 mL, 74.5 mmol, 3.0 equiv) in methylene chloride (68 mL) was added 
dropwise. The reaction was warmed to room temperature and stirred for 5 h. Upon 
reaction completion the crude reaction mixture was poured into ice water and stirred for 1 
h. The aqueous layer was extracted with methylene chloride three times. The combined 
extracts were washed with water and dried with sodium sulfate, and concentrated by 
rotary evaporator. The crude solid was then rinsed with hexanes to afford 6-bromo-2,3-
dihydroxybenzaldehyde (SI1) as an orange solid (4.58 g, 21.1 mmol, 85% yield). 1H 
O
OHBr
OMe
BBr3
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O
OHBr
OH
95% yield
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NMR (300 MHz, CDCl3) δ 12.24 – 12.06 (m, 1H), 10.27 (s, 1H), 7.17 – 6.95 (m, 2H), 
5.65 (s, 1H). All characterization data match those reported.3 
 
 
 
6-bromo-2-hydroxy-3-(2-methoxyethoxy)benzaldehyde (SI2): Sodium hydride (1.17 
g, 48.75 mmol, 2.3 equiv) was added to a flame-dried flask under argon.  This flask 
placed in an ice bath, and a solution of 6-bromo-2,3-dihydroxybenzaldehyde (SI1, 4.6 g, 
21.2 mmol, 1.0 equiv) in DMSO (42 mL) was added dropwise. The resulting solution 
was stirred for 3 hours and then 2-methoxyethyl 4-methylbenzenesulfonate4 (5.37 g, 
23.22 mmol, 1.1 equiv) in DMSO (4.2 mL) was added dropwise. The reaction was stirred 
for 24 hours at room temperature. The reaction was quenched with water and the pH was 
checked and adjusted to pH = 7.  The aqueous layer was extracted with methylene 
chloride three times and the combined organic extracts were washed with 1M HCl, dried 
with Na2SO4, and then concentrated. The crude reaction mixture was filtered through a 
pad of silica and concentrated to afford 6-bromo-2-hydroxy-3-(2-
methoxyethoxy)benzaldehyde as an yellow solid (3.38 g, 12.3 mmol, 58% yield); 1H 
NMR (300 MHz, CDCl3) δ 12.25 (s, 1H), 10.29 (s, 1H), 7.07 (d, J = 8.6 Hz, 1H), 6.99 (d, 
J = 8.6 Hz, 1H), 4.23 – 4.15 (m, 2H), 3.82 – 3.75 (m, 2H), 3.45 (s, 3H); 13C NMR (101 
MHz, CDCl3) δ 198.5, 155.3, 147.8, 123.6, 121.3, 117.6, 71.0, 69.4, 59.4; IR (neat) 2984, 
2942, 2933, 2932, 2750, 1686, 1641, 1579, 1467, 1454, 1438, 1388, 1370, 1332, 1317, 
1285, 1274, 1250, 1211, 1202, 1127, 1102, 1081, 898, 861, 822, 789, 749, 676; HRMS 
C10H12BrO4 (M+H)+: 274.9913, Found: 274.9921.  
 
The corresponding aldehydes for other ligands tested were synthesized according to the 
procedure described above. 
 
 
 
O
OHBr
O
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Synthesis of Salen Crown Ether Ligands: Imine Formation 
 
                 
                            
 
6,6'-((1E,1'E)-(((R)-[1,1'-binaphthalene]-2,2'-
diyl)bis(azanylylidene))bis(methanylylidene))bis(5-bromo-2-(2-
methoxyethoxy)phenol)(L7):  6-bromo-2-hydroxy-3-(2-methoxyethoxy)benzaldehyde 
(2.38 g, 8.67 mmol, 2.0 equiv) and (R)-(+)-1,1′-Binaphthyl-2,2′-diamine (1.7 g, 4.33 
mmol, 1.0 equiv) were combined in EtOH (14 mL). The reaction mixture was heated to 
120 °C and stirred for 6 h.  Upon completion the reaction was cooled to room 
temperature and subsequently filtered. The filtered solid were washed with EtOH, 
concentrated under reduced pressure, affording scarlet solids (2.69 g, 3.36 mmol, 77% 
yield); [α]D20 = –301.6 (c 0.652, CH2Cl2); 1H NMR (400 MHz, C6D6) δ 13.84 (s, 1H), 
9.08 (s, 1H), 7.65 (d, 12 Hz, 1H), 7.56 (d, 8 Hz, 1H), 7.30 (d, 12 Hz, 1H), 7.25 (d, 8 Hz, 
1H), 7.03 (t, 8 Hz, 1H), 6.87 (t, 8 Hz, 1H), 6.54 (d, 8 Hz, 1H), 6.12 (d, 8Hz, 1H), 3.55 (t, 
6 Hz, 2H), 3.21 (t, 4 Hz, 2H), 3.01 (s, 3H); 13C NMR (75 MHz, C6D6) δ 162.8, 155.0, 
147.8, 143.6, 133.5, 132.8, 130.3, 129.4, 128.4, 127.2, 126.5, 126.1, 121.7, 118.2, 117.6, 
117.0, 116.8, 70.7, 68.8, 58.5; IR (neat) 2925, 2876, 2817, 1600, 1586, 1440, 1338, 1246, 
1224.50, 1125, 1085, 871, 814, 790, 752; HRMS (EI) Calcd. for C40H34Br2N2O6: 
796.0784, Found: 796.0782. 
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6,6'-((1E,1'E)-(((R)-[1,1'-binaphthalene]-2,2'-
diyl)bis(azanylylidene))bis(methanylylidene))bis(2-(2-methoxyethoxy)phenol)(L1):  
2-hydroxy-3-(2-methoxyethoxy)benzaldehyde (365 mg, 1.86 mmol, 2.0 equiv) and 
(R)-(+)-1,1′-binaphthyl-2,2′-diamine (264.5 mg, 0.930 mmol, 1.0 equiv) were combined 
in EtOH (7 mL). The reaction mixture was stirred at room temperature for 48 h. The 
suspension was filtered. The filtered solid were washed with EtOH, concentrated under 
reduced pressure, affording orange solids (556.8 mg, 0.869 mmol, 94% yield); [α]D20 = –
371.3 (c = 0.6, CH2Cl2);  1H NMR (400 MHz, CDCl3) δ 12.33 (s, 2H), 8.05, 8.02 (d, J = 
12 Hz, 2H), 8.55 (s, 2H), 7.93, 7.91 (d, J = 8 Hz, 2H), 7.54, 7.51 (d, J = 12 Hz, 2H), 7.40 
– 7.44 (t, J = 8 Hz, 2H), 7.22 – 7.24 (d, J = 8 Hz, 2H), 7.19, 7.17 (d, J = 8 Hz, 2H), 6.89, 
6.88 (d, J = 4 Hz, 2H), 6.80, 6.79 (d, J = 4 Hz, 2H), 6.66 – 6.70 (t, J = 8 Hz, 2H), 4.03 –
4.06 (m, 4H), 3.65 – 3.68 (t, J = 6 Hz, 4H),  3.39 (s, 6H); HRMS (EI) Calcd. for 
C40H36N2O6: 640.2573, Found: 640.2573. 
 
 
 
 
 
 
 
 
 
 
N N
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6,6'-((1E,1'E)-(((R)-[1,1'-binaphthalene]-2,2'-
diyl)bis(azanylylidene))bis(methanylylidene))bis(2-(2-(2-
methoxyethoxy)ethoxy)phenol)(L3): 
2-hydroxy-3-(2-(2-methoxyethoxy)ethoxy)benzaldehyde (191.3 mg, 0.797 mmol, 2.0 
equiv) and (R)-(+)-1,1′-binaphthyl-2,2′-diamine (96.4 mg, 0.339 mmol, 1.0 equiv) were 
combined in EtOH (3 mL). The reaction mixture was stirred at room temperature for 48 
h. The suspension was filtered. The filtered solid were washed with EtOH, and 
concentrated under reduced pressure to afford an orange solid (196.5 mg, 0.2697 mmol, 
80% yield); [α]D20 = –352.1 (c 0.518, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 12.28 (s, 
2H), 8.03 (d, J = 8 Hz, 2H ), 7.92 (d, J = 8 Hz, 2H), 7.52 (d, J = 8 Hz, 2H), 7.44-7.40 (m, 
2H), 7.26-7.22 (m, 2H), 7.18 (d, J = 8 Hz, 2H), 6.88 (d, J = 8 Hz, 2H), 6.79 (d, J = 8 Hz, 
2H), 6.70 – 6.66 (m, 2H), 4.09 – 4.06 (m, 4H), 3.79 – 3.76 (m, 4H), 3.67 – 3.65 (m, 4H), 
3.53 – 3.51 (m, 4H), 3.37 (s, 6H); 13C NMR (75 MHz, CDCl3) δ 163.0, 151.7, 147.2, 
144.4, 133.3, 132.6, 130.2, 128.4, 127.0, 126.6, 125.8, 124.9, 119.7, 118.2, 118.0, 117.8, 
72.0, 70.7, 69.7, 69.1, 59.1; IR (neat) 3269, 3046, 2955, 2362, 1603, 1574, 1506, 1470, 
1429, 1389, 1359, 1306, 1261, 1194, 1143, 1087, 969, 856, 815, 744, 700; HRMS (EI) 
Calcd. for C44H44N2O8: 728.3098, Found: 728.3096.  
 
 
6,6'-((1E,1'E)-(((1R,2R)-cyclohexane-1,2-
diyl)bis(azanylylidene))bis(methanylylidene))bis(2-(2-methoxyethoxy)phenol)(L5):  
  2-hydroxy-3-(2-methoxyethoxy)benzaldehyde (193 mg, 0.986 mmol, 2.0 equiv) and 
(1R,2R)-cyclohexane-1,2-diamine (56.3 mg, 0.493 mmol, 1.0 equiv) were combined in 
EtOH (8 mL). The reaction mixture was stirred at room temperature for 48 h. The solvent 
was removed under reduced pressure. The residue was purified by column 
L5
N N
OH HO
OO
OO
MeMe
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chromatography on silica-gel (n-hexane/EtOAc = 2/1, 1/2, 1/4), affording an oil (195 mg, 
0.414 mmol, 84% yield): [α]D20 = +120.0 (c = 0.5, CH2Cl2); 1H NMR (300 MHz, CDCl3) 
δ 13.83 (s, 2H), 8.21 (s, 2H), 6.88 – 6.90 (m, 2H), 6.77 – 6.80 (m, 2H), 6.67 – 6.71 (t, J = 
6 Hz, 2H), 4.13 – 4.16 (t, J = 4.5 Hz, 4H), 3.76 – 3.78 (t, J = 3 Hz, 4H), 3.43 (s, 6H), 1.84 
–1.93 (m, 4H), 1.66 –1.69 (d, J = 9 Hz, 2H), 1.42 – 1.47 (m, 2H) ppm; 13C NMR (75 
MHz, CDCl3) δ 164.8, 152.2, 147.4, 124.0, 118.7, 117.9, 116.6, 72.5, 71.2, 68.6, 59.3, 
33.1, 24.1; IR (neat) 3315, 2929, 2856, 1625, 1578, 1477, 1450, 1376, 1338, 1289, 1233, 
1022; HRMS (EI) Calcd. for C26H34N2O6: 470.2417, Found: 470.2425. 
 
 
 
6,6'-((1E,1'E)-(((R)-[1,1'-binaphthalene]-2,2'-
diyl)bis(azanylylidene))bis(methanylylidene))bis(4-bromo-2-(2-
methoxyethoxy)phenol)(L6): 5-bromo-2-hydroxy-3-(2-(2-
ethoxyethoxy)ethoxy)benzaldehyde (80 mg, 0.291 mmol) and (R)-(+)-1,1′-Binaphthyl-
2,2′-diamine (41.232 mg, 0.145 mmol) were combined in EtOH (10 mL). The reaction 
mixture was stirred at room temperature for 48 h. The suspension was filtered. The 
filtered solid were washed with EtOH, concentrated under reduced pressure, affording 
scarlet solids (100 mg, 0.125 mmol, 86% yield); [α]D20 = –298.5 (c 0.5, CH2Cl2); 1H 
NMR (400 MHz, CDCl3) δ 12.32 (s, 2H), 8.45 (s, 2H), 8.02 (d, 12 Hz, 2H), 7.91 (d, 8 Hz, 
2H), 7.48 (d, 12 Hz, 2H), 7.41 (m, 2H), 7.21 (m, 2H), 7.13 (d, 8 Hz, 2H), 6.96 (d, 4 Hz, 
2H), 6.91 (d, 4 Hz, 2H), 4.01 (m, 4H), 3.65 (t, 4Hz, 4H), .38 (s, 6H); 13C NMR (75 MHz, 
CDCl3) δ 161.6, 150.9, 148.2, 143.7, 133.2, 132.8, 130.4, 126.2, 120.4, 120.2, 117.5, 
109.5, 77.5, 77.2, 76.9, 70.8, 69.1, 59.2; IR (neat) 2875, 2360, 2342, 1605, 1569, 1450, 
N N
OH HO
OO
L6
O O
Br Br
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1398, 1363, 1332, 1250, 1199, 1125, 1089, 1026, 972, 900, 817, 751; HRMS (EI) Calcd. 
for C40H34Br2N2O6: 796.0784, Found: 796.0784. 
 
 
 
Complexation Procedure (Ni/L synthesis) 
 
 
 
 
 
 
 
    
 
 
Ni-Salen Complex (Ni-L7):  Ni(OAc)2•4H2O (1.17 g, 4.7 mmol, 1.4 equiv) and L7 (2.69 
g, 3.36 mmol, 1.0 equiv) were combined in EtOH and heated to 100 °C for 12 h. While 
still hot, the crude mixture was transferred into a 20 mL vial, rinsing with a small amount 
of additional EtOH. The vial was placed in the freezer for 12h. The crude mixture was 
then centrifuged down, and the EtOH was decanted. The mother liquor was then reduced 
via rotary evaporator, and the crude reaction mixture was allowed to rest in the freezer, 
and centrifuged a second time. The combined precipitates were washed with hexanes, and 
dried under vacuum to afford a yellow solid (2.2 g, 2.58 mmol, 77% yield).  
 
All other metal complexes were prepared using this identical procedure. 
 
HRMS for the Catalysts with Nickel  
 
The normal spectral region could not be determined by 1H NMR, since Ni(II)-salen 
complexes 1d, 2, 3a-c, 4 and 5 are paramagnetic. High-resolution mass spectra (HRMS) 
shows desired Ni(II)-salen complexes bearing one nickel atom. Similar effects for Ni(II)-
salen complexes have been reported before.5,6  
Ni(OAc)2•4H2O
EtOH
77% yield
N N
O O
OO
Ni-L7
Br Br
O O
Ni
N N
OH HO
OO
L7
Br Br
O O
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L1-Ni: HRMS (EI) Calcd. C40H34N2NiO6: 696.1770, Found: 696.1769 
L2-Ni: HRMS (EI) Calcd. C36H26N2NiO4: 608.1246, Found: 608.1243 
L3-Ni: HRMS (EI) Calcd. C44H42N2NiO8: 784.2295, Found: 784.2294 
L4-Ni: HRMS (EI) Calcd. C42H38N2NiO2: 660.2287, Found: 660.2286 
L5-Ni: HRMS (EI) Calcd. C26H32N2NiO6: 526.1614, Found: 526.1614  
L6-Ni: HRMS (EI) Calcd. C40H33Br2N2NiO6: 853.0059, Found: 853.0068 
L7-Ni: HRMS (EI) Calcd. C40H32Br2N2NiO6: 851.9980, Found: 851.9981  
 
Synthesis of  Trifluoromethylketones: 
 
Aryl trifluoromethylketone 1h was prepared according to a previously reported 
procedure.7 All other aryl trifluoromethylketones were purchased from Alfa Aesar, 
Sigma-Aldrich, or TCI and used without further purification.  
 
Synthesis of Vinyl Trifluoromethylketones: 
 
Previously reported methods were used to prepare 4a8, 4b8, 4c9, 4d8, 4e8, 4i10, 4j10, 4k9, 
and 4n10 . 
 
 
 
 
N N
O O
R1R1
M
L5
L1: R1 = O-CH2CH2O-CH3
L2: R1 = O-CH3
L3: R1 = O-[CH2CH2O]2-CH3
L4: R1 = t-Bu
N N
O O
OO
OO
MeMe
M
R2
R3 R3
L6: R2 = Br, R3 = H
L7: R2 = H, R3 = Br
R2
N N
O O
OO
OO
MeMe
M
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General Procedure for the Synthesis of Vinyl Trifluoromethylketones: 
 
                  
(E)-1,1,1-trifluoro-4-(m-tolyl)but-3-en-2-one (4g): 3-methylbenzaldehyde (601 mg, 5.0 
mmol, 1.0 equiv), piperidine (493 µL, 5.0 mmol, 1.0 equiv) and acetic acid ( 429 µL, 7.5 
mmol, 1.5 equiv) were all combined in dry toluene (5 mL) in a flame-dried flask under 
argon. The resultant solution was cooled to 0 °C, and then trifluoroacetone (1.8 mL, 20 
mmol, 4 equiv) in toluene (5 mL) was added slowly. The reaction was stirred at 0 °C for 
2 hours and then allowed to stir at room temperature for 24 h. The reaction was quenched 
with saturated ammonium chloride solution and the aqueous layer was extracted three 
times with ethyl acetate. The combined organic extracts were washed with water, and 
dried with sodium sulfate.   Product 4g purified by column chromatography (5% EtOAc 
in hexanes) to provide a colorless oil (415 mg, 38% yield); 1H NMR (500 MHz, CDCl3) δ 
7.95 (d, J = 15.9 Hz, 1H), 7.48 – 7.42 (m, 2H), 7.37 – 7.29 (m, 2H), 7.01 (dq, J = 16.0, 
1.0 Hz, 1H), 2.41 (t, J = 0.7 Hz, 3H). All characterization data match those reported.11 
 
 
(E)-1,1,1-trifluoro-4-(o-tolyl)but-3-en-2-one (4h):  Product 4h purified by column 
chromatography (8% EtOAc in hexanes) to provide a colorless oil (107 mg, 50% yield); 
1H NMR (300 MHz, CDCl3) δ 8.31 (dt, J = 15.9, 0.6 Hz, 1H), 7.74 – 7.64 (m, 1H), 7.38 
(td, J = 7.3, 1.4 Hz, 1H), 7.26 (m, 2H), 6.96 (dq, J = 15.8, 0.9 Hz, 1H), 2.50 (s, 3H). All 
characterization data match those reported.11 
 
 
4gMe
CF3
O
Me
H
O
HOAc, piperidine
toluene, 0 °C to 23 °CMe CF3
O
Me 4h
CF3
O
N
Me 4l
CF3
O
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(E)-1,1,1-trifluoro-4-(1-methyl-1H-indol-3-yl)but-3-en-2-one (4l): Product 4l purified 
by column chromatography (20% EtOAc in hexanes) to provide a yellow oil (192 mg, 
15% yield); 1H NMR (500 MHz, CDCl3) δ 8.21 (dd, J = 15.5, 0.7 Hz, 1H), 7.97 – 7.91 
(m, 1H), 7.58 (s, 1H), 7.44 – 7.32 (m, 3H), 6.97 (dt, J = 15.6, 1.0 Hz, 1H), 3.88 (s, 3H). 
All characterization data match those reported.12 
 
 
(E)-1,1,1-trifluoro-4-(naphthalen-2-yl)but-3-en-2-one (4m): Product 4m purified by 
column chromatography (8% EtOAc in hexanes) to provide a light yellow oil (500 mg, 
40% yield); 1H NMR (500 MHz, CDCl3) δ 8.19 – 8.05 (m, 2H), 7.95 – 7.86 (m, 3H), 7.75 
(dd, J = 8.6, 1.8 Hz, 1H), 7.64 – 7.52 (m, 2H), 7.13 (dq, J = 16.0, 0.9 Hz, 1H). All 
characterization data match those reported.13 
 
 
tert-butyl (E)-4-(4,4,4-trifluoro-3-oxobut-1-en-1-yl)benzoate (4f): Product 4f was 
prepared using the general procedure and purified by column chromatography (8% 
EtOAc in hexanes) to provide a colorless oil (687 mg, 2.3 mmol, 46% yield); 1H NMR 
(400 MHz, CDCl3) δ 8.05 (d, J = 8.1 Hz, 2H), 7.97 (d, J = 16.0 Hz, 1H), 7.68 (d, J = 8.1 
Hz, 2H), 7.07 (dt, J = 16.0, 1.0 Hz, 1H), 1.61 (d, J = 0.9 Hz, 9H); 13C NMR (101 MHz, 
CDCl3) δ 164.8, 148.8, 136.9, 135.2, 130.3, 129.0, 118.5, 82.0, 28.30; 19F NMR (282 
MHz, CDCl3) δ –77.66; IR (Neat Film, NaCl) 3051, 2995, 1709, 1613, 1568, 1417, 1392, 
1368, 1305, 1265, 1189, 1141, 1063, 994, 896, 844, 772, 733, 705, 683 cm–1.  
 
 
Procedure for Enantioselective Alkynylation of Aryl Trifluoromethyl Ketones 
 
To a stirred solution of catalyst (0.012 mmol, 0.05 equiv) in THF (0.5 mL), alkyne 
(0.968 mmol, 4 equiv), 4  molecular sieve (377 mg), and KOtBu (0.484 mmol, 0.2 
equiv) were added at room temperature slowly. After the solution had been stirred at 
4m
CF3
O
t-BuO
O 4f
CF3
O
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room temperature for 30 min to give a dark yellow mixture, ketone (0.242 mmol, 1.0 
equiv) was added dropwise to a solution. After the resulting mixture was stirred at room 
temperature for 24 h, saturated ammonium chloride (2mL) was added to quench the 
reaction. The solution was extracted with ethyl acetate (3×15 mL). The combined organic 
layers were washed with brine, dried over anhydrous magnesium sulfate, and 
concentrated by rotary evaporation. The residue was purified by flash column 
chromatography ethyl acetate/hexane. Enantiomeric excesses were determined by HPLC 
on chiral stationary phase (Daicel Chiralpak IB or ID column (0.46 cm × 25 cm)).  
 
 
1,1,1-trifluoro-2,4-diphenylbut-3-yn-2-ol (3aa) : Product 3aa was prepared using the  
general procedure to provide a pale yellow oil (93% yield, 93% ee); [α]D24 = +26.8 (c = 
0.5, CH2Cl2); The enantiomeric excess was determined by chiral HPLC analysis: Daicel 
Chiralpak IB column; Hexane/i-PrOH = 98:2; flow rate 1 mL/min, 254 nm wave length 
UV; minor tR = 11.081 min, major tR = 9.556 min. All characterization data match those 
reported. 14 
 
 
1,1,1-trifluoro-2-(4-fluorophenyl)-4-phenylbut-3-yn-2-ol (3ba): 
Product 3ba was prepared using the general procedure to provide a pale yellow oil (93% 
yield, 90% ee); [α]D24 = +25.2 (c = 0.5, CH2Cl2); The enantiomeric excess was 
determined by chiral HPLC analysis: Daicel Chiralpak ID column; Hexane/i-PrOH = 
99:1; flow rate 0.5 mL/min, 254 nm wave length UV; minor tR = 11.809 min, major tR = 
11.014 min. All characterization data match those reported.15 
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2-(4-chlorophenyl)-1,1,1-trifluoro-4-phenylbut-3-yn-2-ol (3ca): Product 3ca was 
prepared using the  general procedure to provide a pale yellow oil (94% yield, 89% ee); 
[α]D24 = +17.8 (c = 0.5, CH2Cl2); The enantiomeric excess was determined by chiral 
HPLC analysis: Daicel Chiralpak ID column; Hexane/i-PrOH = 99:1; flow rate 0.5 
mL/min, 254 nm wave length UV; minor tR = 12.818 min, major tR = 11.254 min. All 
characterization data match those reported.14 
 
 
2-(4-bromophenyl)-1,1,1-trifluoro-4-phenylbut-3-yn-2-ol (3da): Product 3da was 
prepared using  the general procedure to provide a pale yellow oil (97% yield, 89% ee); 
[α]D24 = +14.2 (c = 0.8, CH2Cl2); The enantiomeric excess was determined by chiral 
HPLC analysis: Daicel Chiralpak ID column; Hexane/i-PrOH = 99:1; flow rate 0.5 
mL/min, 254 nm wave length UV; minor tR = 14.004 min, major tR = 11.924 min. All 
characterization data match those reported.15 
 
 
(R)-1,1,1-trifluoro-2-(4-methoxyphenyl)-4-phenylbut-3-yn-2-ol (3ea): Product 3ea 
was prepared using the general procedure to provide a pale yellow oil (86% yield, 97% 
ee); [α]D24 = +22.7 (c = 0.6, CH2Cl2); The enantiomeric excess was determined by chiral 
HPLC analysis: Daicel Chiralpak IB column; Hexane/i-PrOH = 98:2; flow rate 1 
mL/min, 254 nm wave length UV; minor tR = 12.240 min, major tR = 22.694 min. All 
characterization data match those reported.14 
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1,1,1-trifluoro-4-phenyl-2-(p-tolyl)but-3-yn-2-ol (3fa): Product 3fa was prepared using 
the general procedure to provide a pale yellow oil (86% yield, 97% ee); [α]D24 = +22.4 (c 
= 0.6, CH2Cl2); The enantiomeric excess was determined by chiral HPLC analysis: 
Daicel Chiralpak ID column; Hexane/i-PrOH = 99:1; flow rate 1 mL/min, 254 nm wave 
length UV; minor tR = 8.663 min, major tR = 7.225 min. All characterization data match 
those reported.14 
 
 
2-(3-bromophenyl)-1,1,1-trifluoro-4-phenylbut-3-yn-2-ol (3ga) : Product 3ga was 
prepared using the general procedure to provide a pale yellow oil (92% yield, 85% ee); 
[α]D24 = +23.0 (c = 0.7, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.96 (s, 1H), 7.74 (d, 8 
Hz, 1H), 7.53 (m, 3H), 7.35 (m, 3H), 7.29 (t, 8 Hz, 1H), 3.25 (s, 1H); 13C NMR (75 MHz, 
CDCl3) δ 137.6, 132.8, 132.2, 130.44, 129.9, 128.6, 126.1, 125.2, 122.5, 121.4, 120.7, 
88.7, 83.8, 73.1, 72.7; 19F NMR (282 MHz, CDCl3) δ –80.08; IR (Neat) 3547, 3066, 
2233, 1594, 1570, 1490, 1473, 1444, 1423, 1348, 1246, 1168, 1111, 1074, 1012, 997, 
937, 884, 782, 755, 735, 708, 687; HRMS (EI) Calcd. for C16H10BrF3O: 353.9867, 
Found: 353.9871. The enantiomeric excess was determined by chiral HPLC analysis: 
Daicel Chiralpak ID column; Hexane/i-PrOH = 99:1; flow rate 0.5 mL/min, 254 nm wave 
length UV; minor tR = 12.137 min, major tR = 11.398 min.  
 
 
1,1,1-trifluoro-2-(2-fluorophenyl)-4-phenylbut-3-yn-2-ol (3ha): Product 3ha was 
prepared using the general procedure to provide a pale yellow oil (70% yield, 87% ee); 
HO CF3
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[α]D24 = +10.6 (c = 0.2, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.83 (m, 1H), 7.53 (m, 
2H), 7.32 (m, 4H), 7.11(m, 2H), 3.55 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 162.4, 158.9, 
132.2, 131.8, 131.7, 129.9, 129.6, 128.5, 124.3, 124.2, 121.0, 117.0, 116.7, 88.2, 83.1, 
72.4, 71.9; 19F NMR (282 MHz, CDCl3) δ –80.24, –110.69; IR (neat) 3576, 2927, 2235, 
1655, 1613, 1585, 1489, 1453, 1377, 1249, 1228, 1174, 1153, 1120, 1000, 1010, 922, 
823, 755, 740, 711, 689;  HRMS (EI) Calcd. for C16H10F4O: 294.0668, Found: 294.0670; 
The enantiomeric excess was determined by chiral HPLC analysis: Daicel Chiralpak ID 
column; Hexane/i-PrOH = 99:1; flow rate 1 mL/min, 254 nm wave length UV; minor tR 
= 7.523 min, major tR = 6.467 min.  
 
 
(R)-1,1,1-trifluoro-2-phenyl-4-(p-tolyl)but-3-yn-2-ol (3ab) : Product 3ab was prepared 
using the general procedure to provide a pale yellow oil (98% yield, 91% ee); [α]D24 = 
+18.0 (c = 0.2, CH2Cl2); The enantiomeric excess was determined by chiral HPLC 
analysis: Daicel Chiralpak IB column; Hexane/i-PrOH = 98:2; flow rate 1 mL/min, 254 
nm wave length UV; minor tR = 12.079 min, major tR = 8.448 min. All characterization 
data match those reported.15 
 
 
(R)-4-(4-bromophenyl)-1,1,1-trifluoro-2-phenylbut-3-yn-2-ol (3ac): Product 3ac was 
prepared using general procedure to provide a pale yellow oil (90% yield, 91% ee); [α]D24 
= +29.9 (c = 0.7, CH2Cl2); 1H NMR (400 MHz, CDCl3) δ 7.80 (m, 2H), 7.38(m, 7H), 
3.19(s, 1H); 13C NMR (75 MHz, CDCl3) δ 135.1, 133.6, 131.9, 129.7, 128.4, 127.2, 
125.3, 124.2, 121.5, 119.9, 87.1, 85.6, 73.7, 73.3; 19F NMR (282 MHz, CDCl3) δ –80.06; 
IR (neat) 3566, 2926, 2360, 2234, 1605, 1587, 1452, 1394, 1361, 1248, 1166, 1116, 
1098, 1064, 1012, 932, 906, 822, 761, 729, 696, 668; HRMS (EI) Calcd. for 
HO CF3
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C16H10BrF3O: 353.9867, Found: 353.9868; The enantiomeric excess was determined by 
chiral HPLC analysis: Daicel Chiralpak IB column; Hexane/i-PrOH = 98:2; flow rate 1 
mL/min, 254 nm wave length UV; minor tR = 13.405 min, major tR = 9.004 min. 
 
 
(R)-1,1,1-trifluoro-2-phenyl-4-(p-tolyl)but-3-yn-2-ol (3ae) : Product 3ae was prepared 
using general procedure to provide a pale yellow oil (94% yield, 90% ee); [α]D24 = +26.5 
(c = 0.6, CH2Cl2); The enantiomeric excess was determined by chiral HPLC analysis: 
Daicel Chiralpak IB column; Hexane/i-PrOH = 98:2; flow rate 1 mL/min, 254 nm wave 
length UV; minor tR = 10.213 min, major tR = 7.287 min. All characterization data match 
those reported.15 
 
 
(R)-1,1,1-trifluoro-4-(4-methoxyphenyl)-2-phenylbut-3-yn-2-ol (3ad): Product 3ad 
was prepared using general procedure to provide a pale yellow oil (99% yield, 93% ee); 
[α]D24 = +26.7 (c = 0.2, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 7.81 (m, 2H), 7.41 (m, 
5H), 6.86 (m, 2H), 3.83 (s, 3H), 3.12 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 160.6, 135.6, 
133.7, 129.5, 128.3, 127.3, 114.2, 113.0, 88.3, 83.3, 73.7, 73.2, 55.4, 29.7; 19F NMR (282 
MHz, CDCl3) δ –80.19; IR (neat) 3428, 2923, 2230, 1605, 1570, 1510, 1451, 1359, 1294, 
1248, 1172, 1108, 1065, 1016, 933, 907, 832, 764, 706; HRMS (EI) Calcd. for 
C17H13F3O2: 306.0868, Found: 306.0869; The enantiomeric excess was determined by 
chiral HPLC analysis: Daicel Chiralpak IB column; Hexane/i-PrOH = 98:2; flow rate 1 
mL/min, 254 nm wave length UV; minor tR = 17.337 min, major tR = 12.175 min.  
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(R)-1,1,1-trifluoro-4-(naphthalen-2-yl)-2-phenylbut-3-yn-2-ol (3af): Product 3af was 
prepared using general procedure to provide a pale orange solid (89% yield, 89% ee); 
[α]D24 = +2.59 (c = 0.6, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 8.09 (s, 1H), 7.81 (m, 
5H), 7.47 (m, 6H), 3.23 (s, 1H); 13C NMR (75 MHz, CDCl3) δ 135.5, 133.5, 132.9, 132.7, 
129.7, 128.4, 128.3, 128.2, 128.0, 127.9, 127.4, 127.3, 127.0, 125.5, 121.7, 118.3, 88.6, 
84.8, 73.8, 73.4, 29.8; 19F NMR (282 MHz, CDCl3) δ –80.01; IR (neat) 3528, 3061, 2924, 
2853, 2360, 2228, 1595, 1501, 1488, 1450, 1360, 1226, 1168, 1097, 1063, 1005, 906, 
868, 822, 767, 751, 700, 663; HRMS (EI) Calcd. for C20H13F3O: 326.0918, Found: 
326.0918; The enantiomeric excess was determined by chiral HPLC analysis: Daicel 
Chiralpak IB column; Hexane/i-PrOH = 98:2; flow rate 1 mL/min, 254 nm wave length 
UV; minor tR = 16.764 min, major tR = 11.734 min.  
 
 
(R)-2-(4-chlorophenyl)-1,1,1-trifluoro-4-(4-fluorophenyl)but-3-yn-2-ol (3cb) : 
Product 3cb was prepared using general procedure to provide a pale yellow oil (92% 
yield, 89% ee); [α]D24 = +14.6 (c = 0.7, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 7.71 (d, 
9 Hz, 2H), 7.49 (m, 2H), 7.40 (m, 2H), 7.03 (m, 2H), 3.10 (s, 1H); 13C NMR (75 MHz, 
CDCl3) δ 165.1, 161.7, 135.9, 134.3, 134.2, 133.8, 128.7, 128.6, 125.2, 121.4, 116.9, 
116.2, 115.9, 87.4, 83.8, 73.3, 72.8; 19F NMR (282 MHz, CDCl3) δ –80.27, –108.15; IR 
(neat) 3453, 2928, 2235, 1706, 1652, 1601, 1507, 1491, 1406, 1359, 1233, 1184, 1121, 
1093, 1010, 949, 917, 765, 730, 717, 694; HRMS (EI) Calcd. for C16H9ClF4O: 328.0278, 
Found: 328.0278; The enantiomeric excess was determined by HPLC through chiral 
HPLC analysis: Daicel Chiralpak IB column; Hexane/i-PrOH = 98:2; flow rate 1 
mL/min, 254 nm wave length UV; minor tR = 9.181 min, major tR = 7.976 min. 
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(R)-1,1,1-trifluoro-2-(4-methoxyphenyl)-4-(p-tolyl)but-3-yn-2-ol (3ee): Product 3ee 
was prepared using general procedure to provide a pale yellow oil (92% yield, 96% ee); 
[α]D24 = +17.5 (c = 0.5, CH2Cl2); The enantiomeric excess was determined by chiral 
HPLC analysis: Daicel Chiralpak IB column; Hexane/i-PrOH = 98:2; flow rate 1 
mL/min, 254 nm wave length UV; minor tR = 28.064 min, major tR = 9.684 min.  All 
characterization data match those reported.15 
 
 
(R)-4-cyclopropyl-1,1,1-trifluoro-2-(4-methoxyphenyl)but-3-yn-2-ol (3eg): Product 
3eg was prepared using general procedure to provide a pale yellow solid (93% yield, 96% 
ee); [α]D24 = +3.84 (c = 0.3, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 7.61 (d, 9 Hz, 2H), 
6.89 (m, 2H), 3.82 (s, 3H), 2.93 (s, 1H), 1.26 (m, 1H), 0.76 (m, 4H); 13C NMR (75 MHz, 
CDCl3) δ 160.4, 128.6, 127.9, 125.4, 121.6, 113.5, 92.5, 71.3, 55.4, 8.5; 19F NMR (282 
MHz, CDCl3) δ –80.69; IR (neat) 2994, 2931, 2828, 1605, 1573, 1505, 1458, 1431, 1396, 
1345, 1249, 1204, 1078, 970, 923, 818, 781, 733, 713, 687; HRMS (EI) Calcd. for 
C14H13F3O2: 270.0868, Found: 270.0868; The enantiomeric excess was determined by 
HPLC through chiral HPLC analysis: Daicel Chiralpak ID column; Hexane/i-PrOH = 
99:1; flow rate 1 mL/min, 254 nm wave length UV; minor tR = 12.873 min, major tR = 
11.879 min. 
 
 
(R)-2-(3-chlorophenyl)-4-cyclopropyl-1,1,1-trifluorobut-3-yn-2-ol (3eh): Product 3eh 
was prepared using general procedure to provide a pale yellow oil (95% yield, 80% ee); 
[α]D24 = +2.4 (c = 0.3, CH2Cl2); 1H NMR (300 MHz, CDCl3) δ 7.70 (s, 1H), 7.58 (m, 
1H), 7.30 (m, 2H), 2.95 (s, 1H), 1.32 (m, 1H), 0.78 (m, 4H); 13C NMR (75 MHz, CDCl3) 
δ 137.7, 134.2, 129.6, 129.4, 127.6, 125.5, 93.2, 72.7, 72.1, 70.6, 29.8, 8.6, 0.6 19F NMR 
(282 MHz, CDCl3) δ –80.46; IR (neat) 3458, 3016, 2441, 1597, 1578, 1475, 1428, 1364, 
1261, 1165, 1106, 1076, 1027, 943, 925, 884, 814, 787, 721, 688; HRMS (EI) Calcd. for 
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C13H10ClF3O: 274.0323, Found: 274.0372; The enantiomeric excess was determined by 
chiral HPLC analysis: Daicel Chiralpak IB column; Hexane/i-PrOH = 99:1; flow rate 1 
mL/min, 254 nm wave length UV; minor tR = 9.858 min, major tR = 9.287 min. 
 
Procedure for Enantioselective Alkynylation of Vinyl Trifluoromethyl Ketones 
             
               
n = number of reactions. All reactions were set-up in a N2-filled glovebox.   To a vial 
containing L7-Ni (8.6n mg, 0.01n mmol, 0.05 equiv) was added KOt-Bu (2.24n mg, 0.02 
n mmol, 0.1 equiv) in THF (1.6n mL). The resulting solution was stirred until the solids 
were fully dissolved. To a new 4 dram vial was added 4 Å MS (32 mg) and 
phenylacetylene (88 µL, 0.8 mmol, 4.0 equiv). The L7-Ni + KOt-Bu solution (1.6 mL) 
was then added to this vial, and the solution was stirred for 30 min. The vinyl 
trifluoromethylketone (0.2 mmol, 1.0 equiv) in THF (0.8 mL) was then added and the 
reaction was stirred at 40 °C for 24 h. The reaction was then quenched with sat. NH4Cl 
solution and the aqueous layer was extracted three times with ethyl acetate. The 
combined organic extracts were dried with sodium sulfate and concentrated by rotary 
evaporator. The crude oil was then purified by column chromatography to afford the 
desired product.  
  
  
(R,E)-1,5-diphenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (5aa). Product 5aa was 
purified by column chromatography (8% EtOAc in hexanes) to provide a colorless oil 
(51.8 mg, 86% yield); 90% ee, [α]D25 +11.8 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) 
δ 7.55 (dd, J = 8.0, 1.6 Hz, 2H), 7.48 (dd, J = 8.3, 1.3 Hz, 2H), 7.45 – 7.27 (m, 6H), 7.21 
(d, J = 15.8 Hz, 1H), 6.35 (d, J = 15.8 Hz, 1H), 2.91 (s, 1H); 13C NMR (101 MHz, 
CDCl3) δ 135.8, 135.3, 132.2, 129.7, 129.0, 128.9, 128.6, 127.4, 123.6 (d, J = 285.3 Hz), 
CF3
O
H L7-Ni (5 mol %)
KOt-Bu (10 mol %)
4Å MS, THF (0.1 M)
40 °C, 24 h
4a-n 2a
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122.4, 121.1, 88.7, 82.7, 72.4 (q, J = 32.9 Hz);19F NMR (282 MHz, CDCl3) δ 80.72 IR 
(Neat Film, NaCl) 3412, 3030, 2924, 1491, 1445, 1249, 1187, 1130, 1056, 966, 753, 690 
cm–1; HRMS (MM) m/z calc’d for C18H12F3 [M-OH]+: 285.0886 found 285.0883; SFC 
Conditions: 15% IPA, 2.5 mL/min, Chiralpak OD-H column, λ = 254 nm, tR (min): major 
= 3.89, minor = 4.43. 
 
 
(R,E)-5-phenyl-1-(p-tolyl)-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (5ba):  
Product (5ba) was prepared using general procedure and purified by column 
chromatography (10% EtOAc in hexanes) to provide a colorless oil (62.2 mg, 98% 
yield); 92% ee, [α]D25 +8.5 (c 0.99, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.55 (dd, J = 
8.0, 1.6 Hz, 2H), 7.46 – 7.32 (m, 5H), 7.23 – 7.15 (m, 3H), 6.31 (d, J = 15.8 Hz, 1H), 
2.96 (s, 1H), 2.38 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 139.1, 135.7, 132.5, 132.2, 
129.63, 129.55, 128.6, 127.3, 123.6 (q, J = 285.3 Hz), 121.3, 121.1, 88.7, 82.8, 72.5 (q, J 
= 32.8 Hz); 19F NMR (282 MHz, CDCl3) δ –80.72; IR (Neat Film, NaCl) 3412, 2924, 
1654, 1515, 1491, 1444, 1361, 1249, 1186, 1131, 1054, 968, 797, 756, 727, 689 cm–1; 
HRMS (MM) m/z calc’d for C19H14F3 [M-OH]+:  299.1042 found 299.1041; SFC 
Conditions: 6% IPA, 2.5 mL/min, Chiralpak OD-H column, λ = 254 nm, tR (min): major 
= 14.12, minor = 15.02. 
 
 
(R,E)-1-(4-methoxyphenyl)-5-phenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (5ca): 
Product (5ca) was prepared using general procedure and purified by column 
chromatography (10% EtOAc in hexanes) to provide a colorless oil (63.9 mg, 98% 
yield); 92% ee, [α]D25 +7.7 (c 0.97, CHCl3); 1H NMR (400 MHz, CDCl3 δ 7.58 – 7.50 (m, 
2H), 7.46 – 7.32 (m, 5H), 7.15 (d, J = 15.8 Hz, 1H), 6.94 – 6.85 (m, 2H), 6.20 (dd, J = 
15.8, 0.7 Hz, 1H), 3.83 (s, 3H), 2.92 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 160.3, 
135.3, 132.2, 129.6, 128.7, 128.6, 128.0, 125.0, 122.2, 121.2, 120.1, 114.3, 88.6, 82.9, 
Ph
CF3HO
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 S23 
72.5 (q, 32.8 Hz), 55.5; 19F NMR (282 MHz, CDCl3) δ –80.73; IR (Neat Film, NaCl) 
3411, 2936, 2840, 1654, 1608, 1513, 1466, 1444, 1422, 1250, 1176, 1132, 1106, 1059, 
967, 850, 824, 803, 757, 728, 690 cm–1; HRMS (MM) m/z calc’d for C19H14F3O [M-
OH]+: 315.0991 found 315.0993; SFC Conditions: 15% IPA, 2.5 mL/min, Chiralpak OD-
H column, λ = 254 nm, tR (min): major = 5.17, minor = 5.42. 
 
 
(R, E)-1-(4-fluorophenyl)-5-phenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (5da):  
Product 5da was prepared using general procedure and purified by column 
chromatography (8% EtOAc in hexanes) to provide a colorless oil (61.7 mg, 92% yield); 
91% ee, [α]D25 +12.0 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.54 (dd, J = 8.1, 1.6 
Hz, 2H), 7.45 (dd, J = 8.7, 5.3 Hz, 2H), 7.42 – 7.34 (m, 3H), 7.16 (d, J = 15.8 Hz, 1H), 
7.06 (t, J = 8.7 Hz, 2H), 6.25 (d, J = 15.8 Hz, 1H), 2.92 (s, 1H); 13C NMR (101 MHz, 
CDCl3) δ 164.4, 161.9, 134.6, 132.2, 131.5 (q, J = 3.3 Hz), 129.7, 129.1 (d, J = 8.2 Hz)  
128.6, 125.0, 122.2, 121.0, 116.0, 115.8, 88.8, 82.7, 72.3 (q, J = 32.9 Hz); 19F NMR (282 
MHz, CDCl3) δ –80.76, –112.35; IR (Neat Film, NaCl) 3401, 3056, 2927, 1602, 1510, 
1492, 1444, 1362, 1234, 1187, 1159, 1130, 1094, 1055, 967, 854, 826, 808, 757, 728, 690 
cm–1; HRMS (MM) m/z calc’d for C18H11F4 [M-OH]+: 303.0791 found 303.0794; SFC 
Conditions: 20% IPA, 2.5 mL/min, Chiralpak AD-H column, λ = 254 nm, tR (min): major 
= 7.83, minor = 10.52. 
 
 
(R, E)-1-(4-bromophenyl)-5-phenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (5ea): 
Product 5ea was prepared using general procedure and purified by column 
chromatography (15% Et2O in hexanes) to provide a colorless oil (70.8 mg, 93% yield); 
90% ee, [α]D25 –0.6 (c 0.98, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.59 – 7.46 (m, 4H), 
7.45 – 7.31 (m, 5H), 7.13 (d, J = 15.8 Hz, 1H), 6.32 (d, J = 15.8 Hz, 1H), 2.93 (s, 1H); 
13C NMR (101 MHz, CDCl3) δ 134.5, 134.2, 132.2, 132.0, 129.8, 128.9, 128.6, 123.5 (q, 
Ph
CF3HO
F 5da
Ph
CF3HO
Br
5ea
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J = 285.4 Hz), 123.1, 123.0, 120.9, 88.9, 82.5, 72.3 (q, J = 33.0 Hz); 19F NMR (282 
MHz, CDCl3) δ –80.71; IR (Neat Film, NaCl) 3400, 1489, 1248, 1187, 1130, 1056, 1010, 
967, 816, 756, 690 cm–1; HRMS (MM) m/z calc’d for C18H11BrF3O [M-OH]+: 362.9991 
found 362.9984; SFC Conditions: 8% IPA, 2.5 mL/min, Chiralpak OD-H column, λ = 
254 nm, tR (min): major = 12.79, minor = 13.56. 
 
 
tert-butyl(R,E)-4-(3-hydroxy-5-phenyl-3-(trifluoromethyl)pent-1-en-4-yn-1-
yl)benzoate (5fa) Product 5fa was prepared using general procedure and purified by 
column chromatography (15% EtOAc in hexanes) to provide a colorless oil (65.9 mg, 
82% yield); 89% ee, [α]D25 –10.4 (c 0.95, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.97 (d, 
J = 8.4 Hz, 2H), 7.58 – 7.47 (m, 4H), 7.45 – 7.32 (m, 3H), 7.22 (d, J = 15.8 Hz, 1H), 6.41 
(d, J = 15.8 Hz, 1H), 2.95 (s, 1H), 1.60 (s, 9H); 13C NMR (101 MHz, CDCl3) δ 165.7, 
139.3, 134.6, 132.2, 132.0, 130.0, 129.7, 128.6, 127.1, 125.0, 124.8, 123.5 (q, J = 285.5 
Hz), 88.7, 82.6, 81.6, 72.2 (q, J = 32.9 Hz), 28.3; 19F NMR (282 MHz, CDCl3) δ –80.66 
IR (Neat Film, NaCl) 3402, 2979, 1711, 1691, 1608, 1478, 1492, 1445, 1394, 1370, 
1317, 1299,1250, 1184, 1127, 1070, 1018, 972, 846, 757, 691, 613 cm–1; HRMS (MM) 
m/z calc’d for C23H20F3O2 [M-OH]+: 385.1410 found 385.1409; SFC Conditions: 10% 
IPA, 2.5 mL/min, Chiralpak IC column, λ = 210 nm, tR (min): minor = 3.47, major = 
4.28. 
 
 
(R,E)-5-phenyl-1-(m-tolyl)-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (5ga) 
Product 5ga was prepared using general procedure and purified by column 
chromatography (8% EtOAc in hexanes) to provide a colorless oil (61.2 mg, 97% yield); 
90% ee, [α]D25 +8.5 (c 0.88, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.53 (dd, J = 8.0, 1.6 
Hz, 2H), 7.43 – 7.31 (m, 3H), 7.30 – 7.21 (m, 3H), 7.17 (d, J = 15.8 Hz, 1H), 7.13 (d, J = 
Ph
CF3HO
t-BuO
O 5fa
Ph
CF3HO
5gaMe
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6.8 Hz, 1H), 6.32 (d, J = 15.8 Hz, 1H), 2.93 (s, 1H), 2.36 (s, 3H); 13C NMR (101 MHz, 
CDCl3) δ 138.5, 135.9, 135.2, 132.2, 129.8, 129.7, 128.8, 128.6, 128.0, 126.1 (q, J = 
229.9 Hz), 124.6, 122.2, 121.1, 88.7, 82.8, 72.5 (q, J = 32.8 Hz), 21.5; 19F NMR (282 
MHz, CDCl3) δ –80.7; IR (Neat Film, NaCl) 3407, 2924, 1490, 1444, 1379, 1252, 1186, 
1130, 1055, 1000, 966, 918, 844, 778, 756, 726, 689, 629 cm–1; HRMS (MM) m/z calc’d 
for C19H14F3 [M-OH]+: 299.1042 found 299.1045; SFC Conditions: 15% IPA, 2.5 
mL/min, Chiralpak OD-H column, λ = 254 nm, tR (min): major = 3.83, minor = 4.20. 
 
 
(R,E)-5-phenyl-1-(o-tolyl)-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (5ha) 
Product 5ha was prepared using general procedure and purified by column 
chromatography (8% EtOAc in hexanes) to provide a colorless oil (57.8 mg, 92% yield); 
86% ee, [α]D25 +15.4 (c 0.87, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.57 – 7.46 (m, 
4H), 7.45 – 7.33 (m, 3H), 7.25 – 7.16 (m, 3H), 6.24 (d, J = 15.7 Hz, 1H), 2.93 (s, 1H), 
2.42 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 136.4, 134.5, 133.8, 132.2, 130.6, 129.7, 
128.8, 128.6, 126.4, 126.3, 123.7, 123.6 (q, J = 285.3 Hz), 121.1, 88.7, 82.9, 72.6 (q, J = 
32.8 Hz), 19.9; 19F NMR (282 MHz, CDCl3) δ –80.73; IR (Neat Film, NaCl) 3411, 3061, 
2926, 1600, 1490, 1462, 1444, 1381, 1261, 1248, 1185, 1133, 1098, 1058, 1000, 967, 
817, 753, 690, 628 cm–1; HRMS (MM) m/z calc’d for C19H14F3 [M-OH]+: 299.1042 
found 299.1043; SFC Conditions: 15% IPA, 2.5 mL/min, Chiralpak OD-H column, λ = 
254 nm, tR (min): major = 3.58, minor = 4.33. 
 
 
(E)-1-(2-methoxyphenyl)-5-phenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (5ia): 
Product 5ia was prepared using general procedure and purified by column 
chromatography (12% EtOAc in hexanes) to provide a colorless oil (59.6 mg, 92% 
yield); 86% ee, [α]D25 +19.5 (c 0.97, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.58 – 7.50 
(m, 3H), 7.48 (d, J = 7.7 Hz, 1H), 7.43 – 7.33 (m, 3H), 7.33 – 7.27 (m, 1H), 6.96 (t, J = 
Ph
CF3HO
Me 5ha
Ph
CF3HO
OMe 5ia
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7.5 Hz, 1H), 6.91 (d, J = 8.3 Hz, 1H), 6.43 (d, J = 15.9 Hz, 1H), 3.88 (s, 3H), 2.88 (s, 
1H). 13C NMR (101 MHz, CDCl3) δ 157.5, 132.2, 131.0, 130.1, 129.6, 128.6, 128.1, 
123.6 (q, J = 285.2 Hz), 124.2, 123.0, 121.3, 120.8, 111.4, 111.2,  88.6, 83.0, 72.8 (q, J = 
32.7 Hz), 55.7; 19F NMR (282 MHz, CDCl3) δ –80.66; IR (Neat Film, NaCl) 3429, 2940, 
2360, 2237, 1599, 1490, 1465, 1248, 1185, 1136, 1103, 1048, 971, 754, 690 cm–1; 
HRMS (MM) m/z calc’d for C19H14F3O [M-OH]+: 315.09860 found 315.09993; SFC 
Conditions: 15% IPA, 2.5 mL/min, Chiralpak OD-H column, λ = 254 nm, tR (min): major 
= 4.95, minor = 5.67. 
 
 
(R,E)-1-(4-bromophenyl)-5-phenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (5ja):  
Product 5ja was prepared using general procedure and purified by column 
chromatography (15% Et2O in hexanes) to provide a colorless oil (52 mg, 89% yield); 
90% ee, [α]D25 –7.42 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.52 (d, J = 8.2 Hz, 
2H), 7.45 – 7.32 (m, 4H), 6.99 (d, J = 15.6 Hz, 1H), 6.42 (m, 2H), 6.29 (d, J = 15.6 Hz, 
1H), 2.85 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 151.1, 143.3, 132.2, 129.7, 128.6, 
123.5 (q, J = 285.3 Hz), 123.5, 121.0, 120.6, 111.8, 111.2, 88.6, 82.6, 72.2 (q, J = 33.1 
Hz); 19F NMR (282 MHz, CDCl3) δ –80.78;  IR (Neat Film, NaCl) 3429, 3060, 2926, 
1661, 1600, 1564, 1491, 1445, 1400, 1300, 1266, 1249, 1188, 1154, 1127, 1056, 1016, 
1000, 960, 928, 884, 844, 804, 757, 742, 728, 690, 673, 654, 612 cm–1; HRMS (MM) m/z 
calc’d for C16H10F3O [M-OH]+: 275.0678 found 275.0668; SFC Conditions: 15% IPA, 
2.5 mL/min, Chiralpak OJ-H column, λ = 210 nm, tR (min): major = 3.12, minor = 3.86. 
 
 
(R,E)-5-phenyl-1-(thiophen-2-yl)-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (5ka): 
Product 5ka was prepared using general procedure and purified by column 
chromatography (8% EtOAc in hexanes) to provide a colorless oil (51.8 mg, 84% yield); 
90% ee, [α]D25 +25.8 (c 0.88, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.54 (dd, J = 8.0, 
Ph
CF3HO
O
5ja
Ph
CF3HO
S
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1.5 Hz, 2H), 7.45 – 7.30 (m, 5H), 7.28 (dd, J = 4.8, 1.5 Hz, 1H), 7.21 (d, J = 15.7 Hz, 
1H), 6.20 (d, J = 15.7 Hz, 1H), 2.94 (s, 1H);13C NMR (101 MHz, CDCl3) δ 137.9, 132.2, 
129.8, 129.7, 128.6, 126.7, 125.2, 125.0, 122.1, 121.0, 88.7, 82.7, 72.4 (q, J = 32.9 Hz); 
19F NMR (282 MHz, CDCl3) δ –80.78; IR (Neat Film, NaCl) 3406, 2924, 1656, 1491, 
1444, 1358, 1308, 1249, 1186, 1126, 1054, 1000, 964, 868, 775, 757, 725, 690, 606 cm–1; 
HRMS (MM) m/z calc’d for C16H10F3S [M-OH]+: 291.045 found 291.045; SFC 
Conditions: 15% IPA, 2.5 mL/min, Chiralpak OD-H column, λ = 210 nm, tR (min): major 
= 4.20, minor = 4.50. 
 
 
 
(R,E)-1-(1-methyl-1H-indol-3-yl)-5-phenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol 
(5la): Product 5la was prepared using general procedure and purified by column 
chromatography (30% EtOAc in hexanes) to provide a yellow oil (32.2 mg, 63% yield); 
96% ee, [α]D25 +4.2 (c 0.95 CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.81 (d, J = 7.8 Hz, 
1H), 7.48 (d, J = 8.1 Hz, 2H), 7.30 (dd, J = 11.5, 4.2 Hz, 4H), 7.26 – 7.19 (m, 2H), 7.18 – 
7.12 (m, 2H), 6.22 (d, J = 15.8 Hz, 1H), 3.71 (s, 3H); 13C NMR (101 MHz, CDCl3) δ 
137.8, 132.2, 130.3, 129.5, 128.8, 128.6, 126.1, 122.6, 121.4, 120.6, 120.3, 117.6, 111.9, 
88.6, 83.3, 73.13 (q, J = 32.8 Hz), 33.1, 29.9; 19F NMR (282 MHz, CDCl3) δ –80.83; IR 
(Neat Film, NaCl) 3382, 2922, 1651, 1535, 1491, 1444, 1378, 1333, 1255, 1184, 1125, 
1060, 960, 787, 758, 741, 691, 645 cm–1; HRMS (MM) m/z calc’d for C21H15F3N [M-
OH]+: 338.1151 found 338.1151; SFC Conditions: 30% IPA, 2.5 mL/min, Chiralpak AD-
H column, λ = 254 nm, tR (min): major = 6.29, minor = 7.80. 
 
 
(R, E)-1-(naphthalen-2-yl)-5-phenyl-3-(trifluoromethyl)pent-1-en-4-yn-3-ol (5ma): 
 Product 5ma was prepared using general procedure and purified by column 
chromatography (10% EtOAc in hexanes) to provide a colorless oil (67.7 mg, 96% 
Ph
CF3HO
N
Me 5la
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 S28 
yield); 92% ee, [α]D25 +13.8 (c 1.0, CHCl3); 1H NMR (400 MHz, CDCl3)  δ 7.90 – 7.80 
(m, 4H), 7.66 (dd, J = 8.7, 1.6 Hz, 1H), 7.58 (d, J = 6.3 Hz, 2H), 7.50 (d, J = 9.4 Hz, 2H), 
7.46 – 7.34 (m, 4H), 6.47 (d, J = 15.8 Hz, 1H), 2.98 (s, 1H); 13C NMR (101 MHz, 
CDCl3) δ 135.9, 133.7, 133.5, 132.7, 132.2, 129.7, 128.62, 128.60, 128.3, 128.2, 127.9, 
126.7, 126.6, 123.2 (q, J = 110.0 Hz), 88.8, 82.8, 72.5 (q, J = 32.9 Hz); 19F NMR (282 
MHz, CDCl3) δ –80.62; IR (Neat Film, NaCl) 3400, 3057, 1652, 1491, 1444, 1361, 1252, 
1186, 1126, 1054, 965, 894, 843, 810 cm–1; HRMS (MM) m/z calc’d for C18H11BrF3O 
[M-OH]+: 335.1042 found 335.1043; SFC Conditions: 8% IPA, 2.5 mL/min, Chiralpak 
IC column, λ = 210 nm, tR (min): major = 6.56, minor = 7.11. 
 
 
 
(R,4E,6E)-1,7-diphenyl-3-(trifluoromethyl)hepta-4,6-dien-1-yn-3-ol (5na): Product 
5na was prepared using general procedure and purified by column chromatography (8% 
EtOAc in hexanes) to provide a colorless oil (28.1 mg, 43% yield); 91% ee, [α]D25 +11.3 
(c 0.67, CHCl3); 1H NMR (400 MHz, CDCl3) δ 7.54 (dd, J = 8.0, 1.6 Hz, 2H), 7.47 – 
7.26 (m, 8H), 6.99 (dd, J = 14.9, 10.4 Hz, 1H), 6.86 (dd, J = 15.4, 10.5 Hz, 1H), 6.74 (d, 
J = 15.5 Hz, 1H), 5.95 (d, J = 14.9 Hz, 1H), 2.85 (s, 1H); 13C NMR (101 MHz, CDCl3) δ 
136.6, 136.5, 135.9, 132.2, 129.7, 128.9, 128.6, 128.4, 126.9, 126.7, 125.6, 123.5 (q, J = 
285.3 Hz), 121.1, 88.6, 82.7, 72.3 (q, J = 33.0 Hz); 19F NMR (282 MHz, CDCl3) δ –
80.78; IR (Neat Film, NaCl) 3396, 3027, 2922, 2850, 1644, 1491, 1447, 1253, 1186, 
1127, 1051, 990, 974, 828, 756, 726, 690 cm–1; HRMS (MM) m/z calc’d for C20H14F3 
[M-OH]+: 311.1042 found 311.1037; SFC Conditions: 35% IPA, 2.5 mL/min, Chiralpak 
AD-H column, λ = 254 nm, tR (min): major = 3.3, minor =4.4. 
 
 
UV-Vis Data for Metal Titration 
 
A sample solution containing L7-Ni (20 M) and different amounts of KOt-Bu (0, 1, 2, 5, 
7, 10, 12, 15, 17, 20, 25, 30, 35, 40, 45, 50, 60, and 70 M) prepared in dry THF, 
Ph
CF3HO
5na
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respectively. After incubation for 30 min at room temperature, UV-Vis spectra were 
recorded at 25 °C and each measurement was repeated thrice. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Job plot 
 A solutions of L7-Ni (40 M) in THF were mixed with solutions of KOtBu in THF (40 
M) at varying ratios. After incubation for 30 min at room temperature, UV-Vis spectra 
were recorded at 25 °C and each measurement was repeated thrice. 
 
                         
Association constant for the binding of L7-Ni and K+ 
 S30 
The program DynaFit was used for non-linear regression fitting of the titration data based 
on absorbance changes observed at 403 nm. From the result of Job plot, the fitting of 
titration data were performed as a 1:1 binding mode. The DynaFit scripts for the binding 
models used are provided below. 
[task] 
   task = fit 
   data = equilibria 
[mechanism] 
   L + M <==> LM : K1 association 
[constants] 
   K1 = 0.5? 
[concentrations] 
   L = 20 
[responses] 
   L = 0.0092? 
   LM = 0.0125 
[data] 
   variable M 
   file C:\./Users/skang/Desktop/dynafit4-win/DynaFit4/input/titration.txt     
[output] 
   directory C:\./Users/skang/Desktop/dynafit4-win/DynaFit4/output  
[end] 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The association constant for the binding of L7-Ni and K+ ion. Ka = 6.6 × 105 M-1. 
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HPLC and SFC data for Trifluoromethyl Alcohol Products: 
Racemic propargylic alcohols were prepared according to reported literature protocols.13,14 
HPLC data for Aryl Trifluoromethyl Ketones: 
Racemic 3aa  
 
 
Enantioenriched 3aa 
 
. 
 
 
 
  
S33 
Racemic 3ba 
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Racemic 3ca 
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Racemic 3da 
 
 
Enantioenriched 3da 
 
 
Racemic 3ea 
 
  
S36 
 
Enantioenriched 3ea 
 
 
Racemic 3fa 
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Enantioenriched 3fa 
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Racemic 3ha 
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Racemic 3ab 
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Enantioenriched 3ac 
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Enantioenriched 3ad 
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Racemic 3af 
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Racemic 3cb 
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Enantioenriched 3ee 
 
 
Racemic 3eg 
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Enantioenriched 3eg 
 
 
Racemic 3eh 
 
 
Enantioenriched 3eh 
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SFC data for Vinyl Trifluoromethyl Ketone Products: 
Racemic 5aa 
 
 
Enantioenriched 5aa 
 
 
 
 
  
S47 
Racemic 5ba 
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Enantioenriched 5da 
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Racemic 5fa 
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Racemic 5ga 
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Enantioenriched 5ha 
 
 
Racemic 5ia 
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Enantioenriched 5ia 
 
 
Racemic 5ja 
 
 
Enantioenriched 5ja 
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Racemic 5ka
 
 
Enantioenriched 5ka 
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Racemic 5la 
 
 
Enantioenriched 5la 
 
 
Racemic 5ma 
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Enantioenriched 5ma 
 
 
Racemic 5na 
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Enantioenriched 5na 
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1H, 13C, 19F NMR Spectra for Ligands Synthesized: 
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13C NMR (101 MHz, CDCl3) of compound SI2 
Infrared spectrum (Thin Film, NaCl) of compound SI2. 
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13C NMR (101 MHz, CDCl3) of compound 4f 
Infrared spectrum (Thin Film, NaCl) of compound 4f. 
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19F NMR (282 MHz, CDCl3) of compound 4f 
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NMR and IR Data for Trifluoromethyl Products 
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13C NMR (101 MHz, CDCl3) of compound 5aa 
 
Infrared spectrum (Thin Film, NaCl) of compound 5aa. 
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19F NMR (282 MHz, CDCl3) of compound 5aa 
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13C NMR (101 MHz, CDCl3) of compound 5ba 
 
Infrared spectrum (Thin Film, NaCl) of compound 5ba. 
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19F NMR (282 MHz, CDCl3) of compound 5ba 
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Infrared spectrum (Thin Film, NaCl) of compound 5ca. 
 
13C NMR (101 MHz, CDCl3) of compound 5ca 
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19F NMR (282 MHz, CDCl3) of compound 5ca 
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13C NMR (101 MHz, CDCl3) of compound 5da 
 
Infrared spectrum (Thin Film, NaCl) of compound 5da 
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19F NMR (282 MHz, CDCl3) of compound 5da 
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13C NMR (101 MHz, CDCl3) of compound 5ea 
 
Infrared spectrum (Thin Film, NaCl) of compound 5ea 
 S99 
 
  
19F NMR (282 MHz, CDCl3) of compound 5ea 
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13C NMR (101 MHz, CDCl3) of compound 5fa 
 
Infrared spectrum (Thin Film, NaCl) of compound 5fa 
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19F NMR (282 MHz, CDCl3) of compound 5fa 
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13C NMR (101 MHz, CDCl3) of compound 5ga 
 
Infrared spectrum (Thin Film, NaCl) of compound 5ga 
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19F NMR (282 MHz, CDCl3) of compound 5ga 
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13C NMR (101 MHz, CDCl3) of compound 5ha 
 
Infrared spectrum (Thin Film, NaCl) of compound 5ha 
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19F NMR (282 MHz, CDCl3) of compound 5ha 
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Infrared spectrum (Thin Film, NaCl) of compound 5ia 
 
13C NMR (101 MHz, CDCl3) of compound 5ia 
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19F NMR (282 MHz, CDCl3) of compound 5ia 
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13C NMR (101 MHz, CDCl3) of compound 5ja 
 
Infrared spectrum (Thin Film, NaCl) of compound 5ja 
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19F NMR (282 MHz, CDCl3) of compound 5ja 
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13C NMR (101 MHz, CDCl3) of compound 5ka 
 
Infrared spectrum (Thin Film, NaCl) of compound 5ka 
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19F NMR (282 MHz, CDCl3) of compound 5ka 
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Infrared spectrum (Thin Film, NaCl) of compound 5la 
 
13C NMR (101 MHz, CDCl3) of compound 5la 
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19F NMR (282 MHz, CDCl3) of compound 5la 
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13C NMR (101 MHz, CDCl3) of compound 5ma 
 
Infrared spectrum (Thin Film, NaCl) of compound 5ma. 
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19F NMR (282 MHz, CDCl3) of compound 5ma 
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13C NMR (101 MHz, CDCl3) of compound 5na 
 
Infrared spectrum (Thin Film, NaCl) of compound 5na 
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19F NMR (282 MHz, CDCl3) of compound 5na 
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13C NMR (101 MHz, CDCl3) of compound SI2 
Infrared spectrum (Thin Film, NaCl) of compound SI2. 
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13C NMR (101 MHz, CDCl3) of compound 4f 
Infrared spectrum (Thin Film, NaCl) of compound 4f. 
  
S67 
 
 
 
 
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
           
    
    
    
    
           
           
           
           
           
  
 
 
 
 
 
 
 
 
19F NMR (282 MHz, CDCl3) of compound 4f 
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